| Q28546560 | A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity |
| Q35445731 | A modular system to evaluate the efficacy of protease inhibitors against HIV-2 |
| Q31033895 | Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease |
| Q31963272 | An Escherichia coli expression assay and screen for human immunodeficiency virus protease variants with decreased susceptibility to indinavir |
| Q37357408 | Analysis and characterization of dimerization inhibition of a multi-drug-resistant human immunodeficiency virus type 1 protease using a novel size-exclusion chromatographic approach |
| Q39877732 | Analysis of cleavage site mutations between the NC and PR Gag domains of Rous sarcoma virus |
| Q28379312 | Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo |
| Q41958450 | Autoprocessing of human immunodeficiency virus type 1 protease miniprecursor fusions in mammalian cells |
| Q24530002 | Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro |
| Q38934936 | C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain |
| Q24795879 | Characterization of the protease domain of Rice tungro bacilliform virus responsible for the processing of the capsid protein from the polyprotein |
| Q47553033 | Context-dependent autoprocessing of human immunodeficiency virus type 1 protease precursors |
| Q37247555 | Cooperative effects of drug-resistance mutations in the flap region of HIV-1 protease |
| Q27646453 | Crystal Structure of Lysine Sulfonamide Inhibitor Reveals the Displacement of the Conserved Flap Water Molecule in Human Immunodeficiency Virus Type 1 Protease |
| Q35838533 | Defining the level of human immunodeficiency virus type 1 (HIV-1) protease activity required for HIV-1 particle maturation and infectivity |
| Q52595330 | Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases. |
| Q27681237 | Extreme Entropy–Enthalpy Compensation in a Drug-Resistant Variant of HIV-1 Protease |
| Q38972969 | Flexible catalytic site conformations implicated in modulation of HIV-1 protease autoprocessing reactions |
| Q31801167 | Genetic selection for dissociative inhibitors of designated protein-protein interactions |
| Q27683192 | HIV-1 Protease-Substrate Coevolution in Nelfinavir Resistance |
| Q83264844 | HIV-1 protease inhibition potential of functionalized polyoxometalates |
| Q42842599 | Human immunodeficiency virus type-1 reverse transcriptase and ribonuclease H as substrates of the viral protease |
| Q33804495 | Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain |
| Q36221068 | Ionization state of the catalytic dyad Asp25/25' in the HIV-1 protease: NMR studies of site-specifically 13C labelled HIV-1 protease prepared by total chemical synthesis |
| Q27637329 | Lack of synergy for inhibitors targeting a multi-drug-resistant HIV-1 protease |
| Q35706925 | Modulation of HIV protease flexibility by the T80N mutation |
| Q35888615 | Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases |
| Q41490002 | Mutations Proximal to Sites of Autoproteolysis and the α-Helix That Co-evolve under Drug Pressure Modulate the Autoprocessing and Vitality of HIV-1 Protease |
| Q59359799 | Overexpression, Purification and Functional Characterisation of Wild-Type HIV-1 Subtype C Protease and Two Variants Using a Thioredoxin and His-Tag Protein Fusion System |
| Q57531335 | Protease-Activatable Scaffold Proteins as Versatile Molecular Hubs in Synthetic Signaling Networks |
| Q36639010 | Rapid structural fluctuations of the free HIV protease flaps in solution: relationship to crystal structures and comparison with predictions of dynamics calculations |
| Q33650307 | Revealing the dimer dissociation and existence of a folded monomer of the mature HIV-2 protease |
| Q34717635 | Role of invariant Thr80 in human immunodeficiency virus type 1 protease structure, function, and viral infectivity |
| Q90449749 | Structural Adaptation of Darunavir Analogues against Primary Mutations in HIV-1 Protease |
| Q27676079 | Structural and Thermodynamic Basis of Amprenavir/Darunavir and Atazanavir Resistance in HIV-1 Protease with Mutations at Residue 50 |
| Q37583444 | Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor |
| Q34526179 | Structural basis and distal effects of Gag substrate coevolution in drug resistance to HIV-1 protease |
| Q37596952 | Structural basis for coevolution of a human immunodeficiency virus type 1 nucleocapsid-p1 cleavage site with a V82A drug-resistant mutation in viral protease |
| Q27663608 | The Effect of Clade-Specific Sequence Polymorphisms on HIV-1 Protease Activity and Inhibitor Resistance Pathways |
| Q30157397 | The folding free-energy surface of HIV-1 protease: insights into the thermodynamic basis for resistance to inhibitors |
| Q36279696 | Three-dimensional solution structure of the HIV-1 protease complexed with DMP323, a novel cyclic urea-type inhibitor, determined by nuclear magnetic resonance spectroscopy |
| Q34048960 | Total chemical synthesis of human T-cell leukemia virus type 1 protease via native chemical ligation |
| Q42059363 | Trp42 rotamers report reduced flexibility when the inhibitor acetyl-pepstatin is bound to HIV-1 protease |
| Q33356201 | Understanding HIV-1 protease autoprocessing for novel therapeutic development |
| Q27644072 | Unique Thermodynamic Response of Tipranavir to Human Immunodeficiency Virus Type 1 Protease Drug Resistance Mutations |
| Q27645052 | X-Ray Crystal Structures of Human Immunodeficiency Virus Type 1 Protease Mutants Complexed with Atazanavir |